Evidence map›Paper›PMID 39189001›Full record

ArticleClinical and translational radiation oncology2024

CT-based different regions of interest radiomics analysis for acute radiation pneumonitis in patients with locally advanced NSCLC after chemoradiotherapy.

Liqiao Hou, Kuifei Chen, Chao Zhou, Xingni Tang, Changhui Yu, Haijian Jia, Qianyi Xu, Suna Zhou, Haihua Yang

Abstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liqiao HouKey Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy , Department of Radiation Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, NO.150 Ximen Street, Linhai, Taizhou City, 317000, Zhejiang Province, China.
Kuifei ChenKey Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy , Department of Radiation Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, NO.150 Ximen Street, Linhai, Taizhou City, 317000, Zhejiang Province, China.
Chao ZhouDepartment of Radiation Oncology, Enze Hospital Affiliated Hospital of Hangzhou Medical College, Zhejiang Province 317000, China.
Xingni TangKey Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy , Department of Radiation Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, NO.150 Ximen Street, Linhai, Taizhou City, 317000, Zhejiang Province, China.
Changhui YuKey Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy , Department of Radiation Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, NO.150 Ximen Street, Linhai, Taizhou City, 317000, Zhejiang Province, China.
Haijian JiaDepartment of Radiation Oncology, Enze Hospital Affiliated Hospital of Hangzhou Medical College, Zhejiang Province 317000, China.
Qianyi XuDepartment of Radiation Oncology, Thomas Jefferson Health System, 8081 Innovation Park Dr., Fairfax, VA, 22003, USA.
Suna ZhouKey Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy , Department of Radiation Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, NO.150 Ximen Street, Linhai, Taizhou City, 317000, Zhejiang Province, China.
Haihua YangKey Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy , Department of Radiation Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, NO.150 Ximen Street, Linhai, Taizhou City, 317000, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To establish a radiomics model using radiomics features from different region of interests (ROI) based on dosimetry-related regions in enhanced computed tomography (CT) simulated images to predict radiation pneumonitis (RP) in patients with non-small cell lung cancer (NSCLC). Methods: Our retrospective study was conducted based on a cohort of 236 NSCLC patients (59 of them with RP≥2) who were treated in 2 institutions and divided into the primary cohort (n = 182,46 of them with RP≥2) and external validation cohort (n = 54,13 of them with RP≥2). Radiomic features extracted from three ROIs were defined as the whole lung (WL), the dose volume histogram (DVH) of the lung V20 (V20_Lung) and the DVH of the V30 of lung minus the planning target volume (PTV) (V30 Lung-PTV). A total of 107 radiomics features were extracted from each ROIs. The Results: Among the three ROIs, the best R model constructed from the LightGBM algorithm demonstrated the strongest discriminative ability in the ROI of V30 Lung-PTV. The corresponding area under the curve (AUC) value was 0.930 (95 % confidence interval (CI): 0.829-0.941). The D model, R model and R+D model achieved AUC values of 0.798 (95 %CI: 0.732-0.865), 0.930 (95 %CI: 0.829-0.941) and 0.940 (95 %CI: 0.906-0.974) in primary cohort, and in external validation cohort, the AUC values were 0.793 (95 %CI:0.637-0.949), 0.887 (95 %CI:0.810-0.993), 0.951 (95CI%:0.891-1.000). Decision curve demonstrate that R+D model could benefit for patients through the assessment of clinical utility. Conclusion: The radiomics model was able to predict the acute RP more effectively in comparison with the traditional dosimetry model. Especially the radiomics model based on the V30 Lung-PTV region was able to achieve a higher accuracy when compared to the other regions.

Indexed as

Computed tomography simulatedNon-small cell cancerRadiation pneumonitisRadiomics

Identifiers

PMID39189001
PMCPMC11345682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.